Fig. 2From: Health state utility estimates for value assessments of novel treatments in Huntington’s disease: a systematic literature reviewComparison of published EQ-5D utility scores and mean time since diagnosis for patients with HDHD = Huntington’s disease; EQ-5D = EuroQol 5-dimensionBack to article page